sibutramine has been researched along with Abnormalities, Drug-Induced in 2 studies
sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride
Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sibutramine is a drug that is used in the treatment of obesity." | 7.73 | Early first-trimester sibutramine exposure : pregnancy outcome and neonatal follow-up. ( Carducci, B; Caruso, A; Cavaliere, AF; De Santis, M; Straface, G, 2006) |
| "Observational cohort studies were conducted using prescription-event monitoring (PEM) to examine the safety profiles of the anti-obesity agents orlistat and sibutramine." | 3.74 | The safety profiles of orlistat and sibutramine: results of prescription-event monitoring studies in England. ( Perrio, MJ; Shakir, SA; Wilton, LV, 2007) |
| "Sibutramine is a drug that is used in the treatment of obesity." | 3.73 | Early first-trimester sibutramine exposure : pregnancy outcome and neonatal follow-up. ( Carducci, B; Caruso, A; Cavaliere, AF; De Santis, M; Straface, G, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Santis, M | 1 |
| Straface, G | 1 |
| Cavaliere, AF | 1 |
| Carducci, B | 1 |
| Caruso, A | 1 |
| Perrio, MJ | 1 |
| Wilton, LV | 1 |
| Shakir, SA | 1 |
2 other studies available for sibutramine and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Early first-trimester sibutramine exposure : pregnancy outcome and neonatal follow-up.
Topics: Abnormalities, Drug-Induced; Adult; Appetite Depressants; Body Mass Index; Counseling; Cyclobutanes; | 2006 |
The safety profiles of orlistat and sibutramine: results of prescription-event monitoring studies in England.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Adverse Drug Reaction Reporting Systems; | 2007 |